Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-24

Clinical Trial Update: Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ramelteon for ADHD-related sleep onset insomnia in adults has completed. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROZEREM (ramelteon)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: ADHD With Sleep Onset Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2013-05-24